Sofwave is ideal for early to moderate laxity and is often used preventatively to maintain skin firmness and slow visible ageing
For investigations targeting the limits of pharmacological weight loss, Retatrutide represents the current frontier
Retatrutide, a newer triple receptor agonist, produces even more dramatic weight loss than tirzepatide in clinical trials, and hair loss on retatrutide follows the same pattern, correlating with weight loss magnitude rather than drug mechanism
The health consequences of excess visceral fat are well documented
The survey defined third-party telehealth prescribers as those who prescribe GLP/GIPs for weight loss to patients who may be under the care of a different traditional primary care physician who is not otherwise part of their practice and is distinct from specialists in their systems network
As these drugs soar in popularity, researchers and physicians are finding uses form them outside the realm of obesity and diabetes